Complaints received from West Bengal on quality of RT-PCR kits; temporary arrangements made: ICMR

Image
Press Trust of India New Delhi
Last Updated : Apr 20 2020 | 11:02 PM IST

The ICMR has received complaints related to repeat testing of patients in West Bengal as the RT-PCR kits were not working properly, it said on Monday.

Temporary arrangements have been made so as to enable the state to handle the crisis, it added.

Addressing its daily briefing on COVID-19, head of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (ICMR) Raman R Gangakhedkar said the RT-PCR kits are approved by the US FDA.

The RT-PCR test is the gold standard for frontline test for COVID-19.

"They (West Bengal) complained that the RT-PCR kits were not working properly because of which they had to do repeat tests.

"One has to keep in mind that such kits need to be kept below 20 degrees Celsius temperature. If the temperature is higher, proper test results are not obtained. The complaint about repeat testings may have arisen since the technician may have kept the kits and tried the tests at room temperature.

"We have told the West Bengal government that the kits we use at NIV are sufficient for 10,000 tests and these kits are available at NICED, Kolkata," Gangakhedkar said, adding that these are being provided for temporary use to enable the state deal with the crisis.

Replying to a question on rapid antibody tests coming under the scanner over quality issues, he said rapid tests are not used for individual diagnosis the world over.

"The rapid antibody test is not used for individual diagnosis, as we do not know how powerful the antibody developed will be against the virus. It can be used for surveillance and consistent errors will not affect assessment of infection trends in epidemiological surveys," Gangakhedkar added.

India procured five lakh rapid antibody testing kits from China last week and these were being distributed to states for the districts with a high-burden of the infection, health ministry officials said.

Regarding some states raising concerns over the quality of the kits, Gangakhedkar said rapid antibody tests are CE-IVD approved and quality tests were already done to check their sensitivity and specificity as claimed, and they were found to be satisfactory.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 20 2020 | 11:02 PM IST

Next Story